SCOPUS 정보 검색 플랫폼

Volumn 16, Issue 9, 2001, Pages 1719-1723

Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: Profound hypocalcemia, rapid response, and prolonged remission

(5) Stuckey, B G A a,b Lim, E M a,b Kent, G N a Ward, L C b Gutteridge, D H b

a Department of Forensic Pathology State Health Laboratories QEII Medical Center (Australia)

b SIR CHARLES GAIRDNER HOSPITAL (Australia)

Author keywords

Bisphosphonates; Hypocalcemia; Hypoparathyroidism; Paget's disease; Secondary hyperparathyroidism

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; ERGOCALCIFEROL; LEVOTHYROXINE SODIUM; MEDRONATE TECHNETIUM TC 99M; PAMIDRONIC ACID; PARATHYROID HORMONE; SANDOCAL; THYROXINE;

ADULT; ARTICLE; BONE SCINTISCANNING; CALCIUM BLOOD LEVEL; CASE REPORT; FEMALE; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; HYPOTHYROIDISM; PAGET BONE DISEASE; REMISSION; SECONDARY HYPERPARATHYROIDISM; SUBTOTAL THYROIDECTOMY; THYROID DISEASE; TREATMENT OUTCOME;

EID: 0034873225 PISSN: 08840431 EISSN: None Source Type: Journal
DOI: 10.1359/jbmr.2001.16.9.1719 Document Type: Article

Times cited : (18)

References (20)

1
- 0023027012
- Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone
- (1986) Ann Rheum Dis , vol.45 , pp. 1012-1018
- Cantrill, J.A.¹ Buckler, H.M.² Anderson, D.C.³

2
- 0022922384
- Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD
- (1986) Bone Miner , vol.1 , pp. 69-78
- Papapoulos, S.E.¹ Harinck, H.I.² Bijvoet, O.L.³ Gleed, J.H.⁴ Fraher, L.J.⁵ O'Riordan, J.L.⁶

3
- 0020362106
- Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease
- (1982) J Clin Endocrinol Metab , vol.55 , pp. 1100-1107
- Harris, S.T.¹ Neer, R.M.² Segre, G.V.³ Petkau, A.J.⁴ Tully, G.L.⁵ Daly, M.⁶ Ports, J.T.⁷

4
- 0020429597
- Long term effects of dichloromethylene diphosphonate in Paget's disease of bone
- (1982) J Clin Endocrinol Metab , vol.54 , pp. 837-844
- Delmas, P.D.¹ Chapuy, M.C.² Vignon, E.³ Charhon, S.⁴ Briancon, D.⁵ Alexander, C.⁶ Edouard, C.⁷ Meunier, P.J.⁸

5
- 0030271659
- Clinical, biochemical, hematologic and radiographic responses in Paget's disease following intravenous pamidronate disodium: A 2-year study
- (1996) Bone , vol.19 , pp. 387-394
- Gutteridge, D.H.¹ Retallack, R.W.² Ward, L.C.³ Stuckey, B.G.⁴ Stewart, G.O.⁵ Prince, R.L.⁶ Kent, G.N.⁷ Bhagat, C.I.⁸ Price, R.I.⁹ Thompson, R.I.¹⁰ Nicholson, G.C.¹¹

6
- 0015432797
- Hypoparathyroidism and Paget's disease: The effect of parathyroid administration
- (1972) J Clin Endocrinol , vol.35 , pp. 693-699
- Genuth, P.M.¹ Klein, L.²

7
- 0014558451
- Osteitis deformans (Paget's disease of bone) complicating hypoparathyroidism
- (1969) Ann Surg , vol.170 , pp. 286-291
- Pitman, G.H.¹ Rhoads, J.E.²

8
- 0032443140
- Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia
- (1998) Clin Oncol , vol.10 , pp. 407-409
- Sims, E.C.¹ Rogers, P.B.² Besser, G.M.³ Plowman, P.N.⁴

9
- 0031799349
- Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate
- (1998) Intern Med , vol.37 , pp. 396-397
- Comlekci, A.¹ Biberoglu, S.² Hekimsoy, Z.³ Okan, I.⁴ Piskin, O.⁵ Sekeroglu, B.⁶ Alakavuklar, M.⁷

10
- 0027364395
- Uptake of alendronate by bone tissue in hypocalcemic and hypercalcemic rats
- (1993) Drug Metab Dispos , vol.21 , pp. 800-804
- Lin, J.H.¹ Chen, I.W.² Deluna, F.A.³

11
- 0027409584
- Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium
- (1993) J Bone Miner Res , vol.8 , pp. 209-217
- Price, R.I.¹ Gutteridge, D.H.² Stuckey, B.G.A.³ Kent, G.N.⁴ Retallack, R.W.⁵ Prince, R.L.⁶ Bhagat, C.I.⁷ Johnston, C.A.⁸ Nicholson, G.C.⁹ Stewart, G.O.¹⁰

12
- 0032964795
- Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate
- (1999) Bone , vol.24 , pp. 139-144
- Stewart, G.O.¹ Gutteridge, D.H.² Price, R.I.³ Ward, L.⁴ Retallack, R.W.⁵ Prince, R.L.⁶ Stuckey, B.G.A.⁷ Kent, G.N.⁸ Bhagat, C.I.⁹ Dhaliwal, S.S.¹⁰

13
- 0019744971
- Clinical and biochemical effects of Paget's disease of bone: Patterns of response to initial treatment and to long-term therapy
- (1981) Metab Bone Dis Relat Res , vol.45 , pp. 301-308
- Siris, E.S.¹ Canfield, R.E.² Jacobs, T.P.³ Stoddart, K.E.⁴ Spector, P.J.⁵

14
- 0004134194
- Does pamidronate dose affect remission rate in Paget's disease?
- February, 1995, Sydney, Australia, (abstract)
- (1995) Second International Symposium on Paget's Disease of Bone , pp. 30
- Stuckey, B.G.A.¹ Gutteridge, D.H.² Ward, L.C.³ Retallack, R.W.⁴ Price, R.I.⁵ Stewart, G.O.⁶ Prince, R.L.⁷ Kent, G.N.⁸ Bhagat, C.I.⁹ Will, R.K.¹⁰

15
- 0017343044
- Technetium-99m-pyrophosphate bone scans in hyperparathyroidism
- (1977) J Nucl Med , vol.18 , pp. 231-235
- Wiegmann, T.¹ Rosenthall, L.² Kaye, M.³

16
- 0023699947
- Non-invasive evaluation of bone formation: Measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease
- (1988) Scand J Clin Lab Invest , vol.48 , pp. 611-619
- Hyldstrup, L.¹ Clemmensen, I.² Jensen, B.A.³ Transbol, I.⁴

17
- 0028200995
- Effects of two oral doses of alendronate in the treatment of Paget's disease of bone
- (1994) Bone , vol.15 , pp. 415-417
- Adami, S.¹ Mian, M.² Gatti, P.³ Rossini, M.⁴ Zamberlan, N.⁵ Bertoldo, F.⁶ Cascio, V.L.⁷

18
- 0030899963
- Alendronate in the treatment of Paget's disease of bone
- (1997) Bone , vol.20 , pp. 263-271
- Khan, S.A.¹ Vasikaran, S.² McCloskey, E.V.³ Beneton, M.N.C.⁴ Rogers, S.⁵ Coulton, L.⁶ Orgee, J.⁷ Coombes, G.⁸ Kanis, J.A.⁹

19
- 0032880957
- Paget's disease: Acquired resistance to one aminobisphosphonate with retained response to another
- (1999) J Bone Miner Res , vol.14 , pp. 79-84
- Gutteridge, D.H.¹ Ward, L.C.² Stewart, G.O.³ Retallack, R.W.⁴ Will, R.K.⁵ Prince, R.L.⁶ Criddle, A.⁷ Bhagat, C.I.⁸ Stuckey, B.G.A.⁹ Price, R.I.¹⁰ Kent, G.N.¹¹ Faulkner, D.L.¹² Geelhoed, E.¹³ Gan, S.K.¹⁴ Vasikaran, S.¹⁵

20
- 0028173194
- The effect of alendronate on renal tubular reabsorption of phosphate
- (1994) Bone Miner , vol.27 , pp. 51-56
- Vasikaran, S.D.¹ O'Doherty, D.P.² McCloskey, E.V.³ Gertz, B.⁴ Kahn, S.⁵ Kanis, J.A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.